ACOG — Alpha Cognition Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1655923 ·
Last close
$8.28
Market Cap
$180.29M
52W High
$9.27
52W Low
$5.33
ADV30
88,971
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,533,798 | 3,262,022 | -8,096,227 | -6,478,018 | 69,248,341 | 54,248,275 | 11,791,836 |
| Dec 2025 | 2,793,076 | 2,540,827 | -7,925,270 | -6,856,306 | 79,730,235 | 66,046,789 | 17,200,060 |
| Sep 2025 | 2,840,858 | 2,212,797 | -5,301,986 | -1,318,074 | 46,301,213 | 35,398,899 | 12,387,403 |
| Jun 2025 | 1,657,687 | 1,123,590 | -5,737,001 | -10,488,952 | 45,122,942 | 39,405,210 | 13,226,626 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,134,079
Investing CF
$-231,541
Financing CF
$39,050,066
CapEx
$-231,541
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.38
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,584,793
Inventory
$6,043,714
Receivables
$3,752,090
ST Investments
—
EBIT TTM
$-27,060,484
Pretax Income TTM
$-25,141,350
Interest Exp TTM
$50,857
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,825,419
EBITDA
$-27,270,894
Free Cash Flow
$-21,670,372
Enterprise Value
$135,839,712
Total Cash
$54,248,276
Total Debt
$0
Shares Out
21,774,104
Trailing EPS
$-1.39
Book Value
$2.64
ROE
-51.7%
ROA
-29.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,220,275 | -22,579,594 | -20,669,875 | 79,730,235 | 17,200,060 | — | -20,380,367 |
| Dec 2024 | 0 | -11,548,636 | -14,788,727 | 50,736,938 | 11,642,111 | — | -7,755,654 |
| Dec 2023 | 0 | -9,617,813 | -13,763,658 | 2,452,170 | 7,155,865 | — | -8,799,565 |
| Dec 2022 | 0 | -13,465,624 | -12,114,698 | 2,950,951 | 4,271,128 | — | -9,241,650 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.63
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DTIL | PRECISION BIOSCIENCES INC | $180.36M | $6.99 | — |
| OTLK | Outlook Therapeutics, Inc. | $182.62M | $0.98 | — |
| VYGR | Voyager Therapeutics, Inc. | $183.08M | $3.03 | — |
| HUMA | Humacyte, Inc. | $176.18M | $0.65 | — |
| PLX | Protalix BioTherapeutics, Inc. | $190.95M | $2.37 | — |
News headlines (Yahoo Finance, 1h cache)
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
2026-07-30 11:50 · Yahoo
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
2026-07-29 12:30 · Yahoo
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains?
2026-07-28 10:55 · Yahoo
Time to Jump In? Raymond James Is Bullish on These 2 Stocks
2026-07-23 17:57 · Yahoo
Raymond James Starts Alpha Cognition (ACOG) at Outperform
2026-07-14 18:08 · Yahoo
Alpha Cognition (ACOG) Stock Fair Value Moves Lower As Analysts Weigh Zunveyl Persistence
2026-07-11 22:08 · Yahoo
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
2026-07-10 12:30 · Yahoo
We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully
2026-06-13 13:52 · Yahoo
Genvor Appoints Donald Kalkofen as Chief Financial Officer
2026-05-21 12:00 · Yahoo
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target
2026-05-17 13:29 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-07-24 16:05:18 | 2026-07-22 | Opaleye Management Inc. | 10% | P - Purchase | 7.82 | 200086 | 1565499 |